A carregar...
Looking forward to new targeted treatments for chronic spontaneous urticaria
The introduction of omalizumab to the management of chronic spontaneous urticaria (CSU) has markedly improved the therapeutic possibilities for both, patients and physicians dealing with this disabling disease. But there is still a hard core of patients who do not tolerate or benefit from existing t...
Na minha lista:
| Publicado no: | Clin Transl Allergy |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5223554/ https://ncbi.nlm.nih.gov/pubmed/28078079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13601-016-0139-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|